Symbols

Symbols

Aime

Products

News

Markets

Watchlist

Brokers

News/

Stock/

MXCT

MXCT News

Newswire

19:22

MaxCyte Sees $17M-$19M Annual Savings through Restructuring, Reiterates SPL Revenue Guidance

18:27

MaxCyte Anticipates Mixed Revenue Outlook for FY25, Projects Decline in Core Revenue

16:09

MaxCyte CFO Set to Transition in 2026, Initiates Successor Search

16:06

MaxCyte Reports Q3 2025 Financial Results, Reiterates Full-Year Guidance

17:28

MaxCyte Q3 2025: $6.4 mln core revenue, reiterates FY25 guidance.

View More

About MXCT

Charts

--

Sector--

Established Date--

Listing Date--

Exchange--

Full-time Employees--

Fiscal Year Ends--

Website

Security Type--

Office address

Business

Introduction

View More